Benjamin Perry
Founder at MPC Therapeutics SA
Profile
Benjamin Perry has founded MPC Therapeutics SA in 2018, where he holds the title of Director.
Currently, he is working as a Principal at Medicxi Ventures (Jersey) Ltd.
since 2022.
Mr. Perry has a doctorate degree from Imperial College London, which he received in 2002, and a graduate degree from Swansea University, which he received in 1999.
Benjamin Perry active positions
| Companies | Position | Start |
|---|---|---|
Medicxi Ventures (Jersey) Ltd.
 Medicxi Ventures (Jersey) Ltd. Investment ManagersFinance Medicxi Ventures (Jersey) Ltd. (Medicxi) is an independent venture capital firm founded in 2016 by Francesco de Rubertis, Michèle Ollier, and Kevin S. Johnson. The firm is headquartered in London. | Private Equity Investor | 2022-10-31 |
MPC Therapeutics SA
 MPC Therapeutics SA BiotechnologyHealth Technology MPC Therapeutics SA is a company based in Plan-les-Ouates, Switzerland. The Swiss company was founded in 2018 by Benjamin Perry and has been led by CEO Raphael Martinou since its inception. | Founder | 2017-12-31 |
Training of Benjamin Perry
| Imperial College London | Doctorate Degree |
| Swansea University | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Medicxi Ventures (Jersey) Ltd.
Medicxi Ventures (Jersey) Ltd. Investment ManagersFinance Medicxi Ventures (Jersey) Ltd. (Medicxi) is an independent venture capital firm founded in 2016 by Francesco de Rubertis, Michèle Ollier, and Kevin S. Johnson. The firm is headquartered in London. | Finance |
MPC Therapeutics SA
MPC Therapeutics SA BiotechnologyHealth Technology MPC Therapeutics SA is a company based in Plan-les-Ouates, Switzerland. The Swiss company was founded in 2018 by Benjamin Perry and has been led by CEO Raphael Martinou since its inception. | Health Technology |
- Stock Market
- Insiders
- Benjamin Perry
